11 research outputs found

    Additional file 1: Table S1. of Work-related diabetes distress among Finnish workers with type 1 diabetes: a national cross-sectional survey

    No full text
    The association of work-related, diabetes-related, and health-related variables with diabetes-related stress at work and HbA1c level, blood glucose high at work, and depressive symptoms. Standardized (β) and non-standardized (B) regression coefficients. (DOCX 14 kb

    Additional file 1: Table S1. of Working people with type 1 diabetes in the Finnish population

    No full text
    Incidence of type 1 diabetes among Finns aged 18–39 years in 1992–2007. Annual numbers for incidence of type 1 diabetes among Finns aged 18–39 years in 1992–2007. (DOCX 18 kb

    Additional file 2: Table S2. of Working people with type 1 diabetes in the Finnish population

    No full text
    Working aged (18–64 years) general Finnish population, and age-standardized prevalence and proportion of type 1 diabetes among working aged individuals, labor force and employed individuals in Finland in 1992–2007. Annual numbers for working aged (18–64 years) general Finnish population, and age-standardized prevalence and proportion of type 1 diabetes among working aged individuals, labor force and employed individuals in Finland in 1992–2007. (DOCX 18 kb

    Coronary Artery Disease–Associated Locus on Chromosome 9p21 and Early Markers of Atherosclerosis

    Full text link
    Background— Genome-wide association studies have recently identified a locus on chromosome 9p21 that influences risk of coronary artery disease (CAD). The effect of the locus on early markers of atherosclerosis is unknown. We examined its association with carotid intima-media thickness (CIMT) and brachial flow-mediated dilatation (FMD). Methods and Results— We genotyped 2277 individuals, age 24 to 39 years, from the Cardiovascular Risk in Young Finns Study with CIMT and FMD measurements and 1295 individuals, age 46 to 76 years, from the Health 2000 Survey with CIMT for rs1333049, the chromosome 9p21 variant showing the strongest association with CAD. Both mean and maximum CIMT were significantly higher (P<0.001) in the older subjects of the Health 2000 Survey compared with the Young Finns Study. However, there was no association of the rs1333049 genotype with either mean or maximum CIMT at either age (P=0.959 and 0.977 for the 2 phenotypes in the Young Finns Study and P=0.714 and 0.725 in the Health 2000 Survey). Similarly, there was no association of the locus with variation in FMD in the Young Finns cohort (P=0.521). Conclusions— The chromosome 9p21 locus does not influence CAD risk through a mechanism that also affects CIMT or induces early changes in FMD. We examined the association with carotid intima-media thickness and brachial flow mediated dilatation of the recently identified susceptibility locus for coronary artery disease on chromosome 9p21. We found no evidence that the risk variant affects either of these early markers of atherosclerosis, suggesting an alternate mechanism for its effect on risk of CAD

    Trans-ethnic fine-mapping narrowed the association signals.

    No full text
    a<p><i>P</i> meta: <i>P</i> values from meta-analysis combining samples of African American, East Asian and European ancestries.</p>b<p>Direction: effect direction of each individual studies in the order of ARIC, MEC, WHI batch1, WHI batch2, HyperGEN, CLHNS, TAICHI, Finnish T2D, Finnish unaffected, Norwegian T2D and Norwegian unaffected.</p>c<p><i>P</i> het: <i>P</i> values for heterogeneity, indicating whether observed effect sizes are homogeneous across ancestry samples.</p>d<p><i>I</i><sup>2</sup>: index of the degree of heterogeneity.</p

    Reported functional variants exhibited the strongest association at a signal (<i>P</i><10<sup>−4</sup>).

    No full text
    *<p>AA, African American; EUR, European; ASN, East Asian.</p

    Lipid loci with multiple signals in Europeans.

    No full text
    a<p>LD (<i>r</i><sup>2</sup>/D′) with SNP showing the strongest evidence of association at each locus.</p>b<p>β: effect size from an additive model and corresponding to the effect allele, in the unit of mmol/L for HDL-C, LDL-C and natural log transformed TG.</p>c<p><i>P</i> values of sequential conditional analyses, in which we added the SNP with the strongest evidence of association into the regression model as a covariate and tested for the next strongest SNP until the strongest SNP showed a conditional <i>P</i> value>10<sup>−4</sup> and had no annotation suggesting potential function.</p>d<p>Variance explained by SNPs at each locus was estimated based on European samples.</p>e<p><i>P</i> values of initial association in African Americans and East Asians.</p

    Trans-ethnic high-density genotyping narrows the association signal at the HDL-C locus <i>PPP1R3B</i>.

    No full text
    <p>Association in Europeans (A), East Asians (B), African Americans (C) and in a combined trans-ethnic meta-analysis (D). Index SNP rs6601299 colored in purple is the variant showing strongest evidence of association in the combined trans-ethnic meta-analysis.</p

    LDL-C locus <i>PCSK9</i> exhibited seven signals in African Americans.

    No full text
    <p>Initial association in the main analysis (A). Residual association in sequential conditional analysis by sequentially adding the lead SNPs into the regression model (B–G). Each SNP was colored according to its LD (<i>r<sup>2</sup></i>) in the PAGE consortium, with the strongest SNP colored in purple and symbols designating genomic annotation defined in the ‘annotation key’. Genomic coordinates refer to build 36 (hg18).</p
    corecore